Skip to main content
. 2023 Mar 9;61(3):2201193. doi: 10.1183/13993003.01193-2022

FIGURE 3.

FIGURE 3

Effect of ecleralimab on sputum eosinophils before and after allergen challenge over 85 days. A blue circle around the study day indicates allergen inhalation challenge (AIC) and a box indicates an allergen challenge triad. Data are presented as mean±se. *: p<0.05 significant difference between ecleralimab and placebo.